Marc Ceulemans works as a Head, Strategic Venture Capital Fund at Novartis. The firm's known portfolio counts 16 companies.
Is Marc Ceulemans a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechCell & Gene TherapyDiagnosticsDrug DiscoveryGenomicsImmunologyMedTechOncologyPharma
Contacts
Affiliated funds' portfolios
Head, Strategic Venture Capital Fund at Novartis, whose known portfolio counts 16 companies
- Octave
- Vor Biopharma
- Patientory
- Orna Therapeutics
- Pliant Therapeutics
- TScan Therapeutics
- CatalYm
- Dren Bio
- Surface Oncology
- Cadent Therapeutics
- Flare Therapeutics
- Medtech Africa
- and 4 more
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Cell & Gene Therapy, Diagnostics and Drug Discovery. Startups operating in these areas may find Marc Ceulemans relevant.
Stage-wise, the deals at Novartis cluster around Growth, Seed and Series A rounds.
The firm portfolio and the focus above give founders context on whether Marc Ceulemans matches their raise.
Colleagues at Novartis
Paolo Malerba
Strategy Lead
London, United Kingdom
Jose Marcilla
President Latin America and Canada (LACan) Region
United States
Beat Steffen
Managing Director Novartis Venture Fund
Basel, Switzerland
Marianne Uteng
Managing Director
Basel, Switzerland
Anja König
Global Head Novartis Venture Fund
Basel, Switzerland
Jason Freeman
Senior Medical Director
Washington, United States
Shejoy Varghese
Managing partner
Ernakulam, India
Md. Sohel Rana
Managing Partner
Bangladesh
Steven Breazzano
Investor
Fairfield, United States
Lauren Silverman
Managing Director
Cambridge, United States
Stefanie D.
Portfolio Reporting Director
Zürich, Switzerland
Frequently asked questions
Who is Marc Ceulemans?
Marc Ceulemans is a corporate venture investor based in Laax, Graubünden, Switzerland, listed as Head, Strategic Venture Capital Fund at Novartis. The known portfolio of that firm counts 16 companies. That portfolio belongs to the firm, not to Marc Ceulemans personally.
What does Marc Ceulemans invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cell & Gene Therapy, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Marc Ceulemans invest at?
Novartis appears in Growth, Seed and Series A rounds across its known deals, and Marc Ceulemans is listed there as Head, Strategic Venture Capital Fund. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Marc Ceulemans listed at?
Marc Ceulemans is listed as Head, Strategic Venture Capital Fund at Novartis. 11 other people in the database share a firm with Marc Ceulemans.
How do I contact Marc Ceulemans?
A LinkedIn page is on file for Marc Ceulemans. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal